Tirzepatide can cause side effects for some patients
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, and Semaglutide, a GLP-1 RA, have shown greater weight loss efficacy than traditional medications like Phentermine/Topiramate (Qsymia), Naltrexone/Bupropion (Contrave), and Phentermine 12,14,15
Consulta a tu endocrinlogo antes de iniciar, modificar o suspender cualquier tratamiento para diabetes u obesidad
Of these 14 semaglutide tablet -treated patients, 7 patients (0.2% of the total semaglutide tablet-treated study population) developed antibodies that cross-reacted with native GLP-1
Compounded tirzepatide from licensed 503A compounding pharmacies typically remains stable for 90 days when stored under optimal conditions